1. US Food and Drug Administration. In vitro companion diagnostic devices. Guidance for industry and Food and Drug Administration staff. ; 2014.
2. US Food and Drug Administration. Principles for codevelopment of an in vitro companion diagnostic device with a therapeutic product. Draft guidance for industry and Food and Drug Administration staff. ; 2016.
3. Establishing a complementary diagnostic for anti-PD-1 immune checkpoint inhibitor therapy;Novotny;Ann Oncol.,2016
4. Development of a PD-L1 complementary diagnostic immunohistochemistry assay (SP142) for atezolizumab;Vennapusa;Appl Immunohistochem Mol Morphol.,2018
5. US Food and Drug Administration. List of cleared or approved companion diagnostic devices. [last updated 13.12.18].